Instead of whinging about all the negative posts, point out some positives that came out of the meeting.
Printable View
Instead of whinging about all the negative posts, point out some positives that came out of the meeting.
Well PEB did go looking for a strong partner from Big Pharma a while ago and were told to come back when they were further down the track. Now they are further down the track with two products on the market and another two almost ready, and a marketing team led by Jackie who most of us seem to think is pretty clued up.
I can see why the management would want to get the full diagnostic suite ready plus some solid results from someone like Kaiser Permanente before going back again, begging. And I'm sure they listen to Jackie on issues like this.
I don’t think it makes them look like hicks or 80s SOEs. There’s a lot of negative talk, including the unexplained comment a few days ago that someone couldn’t take part in this thread because he/she was too busy with Cellmid. Well Cellmid has just got itself a reputed whiz of a sales consultant in New York, but not for its cancer cure – it’s for a hair tonic that is apparently its biggest seller. Selling hair tonic in the US is not exactly the same as selling cancer diagnostics.
Just a few weeks ago a lot of us were angsting about a2 Milk’s share slide and wondering why its management couldn’t produce some good news instead of pouring resources into opening up new markets (ring any bells?). And then we got a takeover proposal out of the blue that sent the SP up 75% with most analysts saying a reasonable takeover price would have to be considerably higher.
Patience is not only a virtue, it's an excellent protection against ulcers, regardless of whether you have PEB shares or are proud of having none. And with a little more patience among us, we might have also retained some of our more knowledgable contributors on this thread. I miss them, and hope they will rejoin us.
There is a very telling comment from the AGM which provides an excellent window into why PEB has returned minus 31% to date this year. CEO commented (presumably with excitement in his voice) that "In 2014, we set out our objectives for the 2015 financial year. We have made excellent progress against ALL OF THESE ..."
Two examples show PEB's goal setting and how hopeless they have been at achieving those goals on time - (1) We know that PEB announced in August 2014 with Kasier Permanente that "The User Program research is scheduled to begin later this year with results completed in early 2015". In reality, the user program only started in July 2015! (2) We also know that PEB announced in Dec 2014 that with Triage that "Cxbladder Triage is now available in New Zealand and will be launched in the USA early in 2015". In reality, they have only this month (August 2015) received CLIA approval to use the test! There is clearly something seriously amiss with their planning which points towards a fundamental lack of understanding of the US market.
Add to that the slippage on just about every front (especially the 'profitability will be achieved with the 2013 capital raising') and it is no wonder the directors themselves are not prepared to put their own money into the lastest capital raising, after urging all shareholders to support it!
Thats because the science has already been pretty well hashed over and given the tick--It is now into the management and selling arena and thats not going as expected--most thought we'd be well on our way by now(including management IMO)
Stretching horizons on timelines is one thing ,but taking hits on losses is another(for Sh)--Has it ever occurred to you that someone else may be more qualified to promote and sell?